期刊文献+

P53、Grb7在胃肠道间质瘤中的表达及临床意义 被引量:1

Clinical significance of P53、Grb7 expression in gastrointestinal stromal tumor
下载PDF
导出
摘要 目的探讨P53、Grb7在胃肠道间质瘤(GIST)中的表达及其与GIST生物学行为的关系,为预测该肿瘤的侵袭潜能提供理论依据和可能的预测指标。方法收集58例手术切除的GIST标本,应用免疫组织化学法检测肿瘤组织中P53和Grb7蛋白的表达,并结合病理形态学及生物学行为评价进行统计学分析。结果肿瘤组织中的P53、Grb7阳性率分别为85.2%、83.3%,并随着GIST恶性分级的增高,其表达均出现递增趋势,差异有显著性意义(P<0.05);与生长方式、肿瘤大小、肿瘤中心有无坏死、肿瘤细胞特殊排列结构亦有明显关系(P<0.05)。结论 P53、Grb7蛋白表达与GIST的发生、发展有关,检测P53、Grb7表达结合特殊病理学形态可以作为评价GIST生物学行为及预后的客观指标。 Objective To investigate the expression of P53,Grb7 protein in gastrointestinal stromal tumor(GIST),and discuss the relationship between their expression and clincopathological characteristics. Methods 58 cases of GIST,were studied for P53,Grb7 by immunohistochemical staining,Their relations with histomor-phology and biological behavior were analyzed statistically.Results The positive expression of P53, Grb7 was 85.2%(46/54),83.3%(43/54) respectively.The express-ion of P53,Grb7 increased significantly according to the malignant increasing(P0.05) and associated with nuclear division、the histological grade、high cellularity、nuclear pleomorphism、tumor necrosis、tumor invasion and perivascular collar-like pattern(P0.05).Conclusion These data shows the expression of p53 and Grb7 and the clinical pathologic characteristics of GISTs are related to the biological potential,grading criteria and progression of GIST,we can provide scientific basis for the therapy and prognosis evaluation of the GISTs.p53,Grb7 in GIST.
作者 刘磊
机构地区 郑州人民医院
出处 《中国实用医药》 2013年第19期3-5,共3页 China Practical Medicine
关键词 胃肠道间质瘤 P53蛋白 Grb7蛋白 免疫组织化学方法 gastrointestinal stromal tumor P53 Grb7 immunohistochemistry
  • 相关文献

参考文献9

  • 1Tanakd S, Sugimachi K, Kawaguchi H, et al Grb7 signal ransduc- tion prot-ein mediates metastatic progression of esophageal carc INO- Ma. J cell physic ol, 2000,183,(3) :411.
  • 2许少峰,付丽.p53研究的新进展[J].中华病理学杂志,2004,33(6):559-561. 被引量:24
  • 3Li CY, Nagasawa H, Dahlberg WK, Little JB, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established hu- man tumor cell lines. Oncogene, 1995,11 ( 9 ) : 1885-1892.
  • 4Dulic V, Kaufmann WK, Wilson S J, Tlsty TD, et al. P53-depend- ent inhibition of cyclin-dependent kinase activities in human, fibro- blasts during radiationinduced G1 arrest Cell, 1994 mar25:76 (60) : 1013-1023. Joypaul BV, Newman EL, Expression of P'53 protein in normal dy- plastic and malignant gastric mucosa an J Pathos, 1993,170 (3) :279-284. study Blanke CD, Demetri GD, van Mehren M, et al. Long-term follow- up of a Phase randomized trial in advanced gastrointestinal stromal tumor(GIST) patients (pts) treated with imatinib mesylate. J Clin Oncol,2006,24 ( 18 s) :9528. Tanaka S, Mori M, Akiyoshi T, et al. Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res, 1997,57 (1) :28.
  • 5Tanaka S, Srgimachi K, Kawaguche H, et al. Grb7 signal ransduc- tion protein mediates metastatic progression of esophageal carcino- ma. J Cell Physiol,2000,183(3) :411.
  • 6石素胜,孙耘田,白月奎,邵永孚,刘秀云.Grb7在胃肠道间质瘤组织中的表达及其临床意义[J].实用癌症杂志,2005,20(2):147-150. 被引量:4
  • 7Dulic V, Kaufmann WK, Wilson S J, Tlsty TD, et al. P53-depend- ent inhibition of cyclin-dependent kinase activities in human, fibro- blasts during radiationinduced G1 arrest Cell, 1994 mar25:76 (60) : 1013-1023.
  • 8Joypaul BV, Newman EL, Expression of P'53 protein in normal dy- plastic and malignant gastric mucosa an J Pathos, 1993,170 (3) :279-284.
  • 9study Blanke CD, Demetri GD, van Mehren M, et al. Long-term follow- up of a Phase randomized trial in advanced gastrointestinal stromal tumor(GIST) patients (pts) treated with imatinib mesylate. J Clin Oncol,2006,24 ( 18 s) :9528.

二级参考文献34

  • 1Kar S, Sakeguchi K, Shimohigashi Y, et al. Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem, 2002,77:15579-15585.
  • 2Zacchi P, Gostissa M, Uchlda T, et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.Nature, 2002,419:853-857.
  • 3Grossman SR. p300/CBP/p53 interaction and regulation of the p53.Eur J Biochem,2001,268 :2773-2778.
  • 4Fujiwara T, Grimm EA, Mukhopadhyay T, et al. A retroviral wildtype p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res, 1993,8:4129-4133.
  • 5Toschi E, Rota R, Antoninl A, et al. Wild-Type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells. J Invest Dermatol,2000, 114.1188-1194.
  • 6Tadahisa S, Philip JT, Timothy SS, et all. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glimna correlates with site-specific phosphorylation. Cancer Res,2002,62:1069-1176.
  • 7Xu L, Tang WH, Huang CC, et all. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med,2001,7 :723-734.
  • 8Mikata K, Uemura H, Ohuchi H, et all. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation. Mol Cancer Ther,2002, 1:247-252.
  • 9Watanabe T, Sullenger BA. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts.Proc Natl Acad Sci U S A,2000,97:8490-8494.
  • 10Hamilton A J, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science, 1999,286:950-952.

共引文献26

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部